Most linked-to pages

Jump to navigation Jump to search

Showing below up to 50 results in range #11,151 to #11,200.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Borjesson PK, et al. Clin. Cancer Res. (2003) cited as Ref 552 in DOI: 10.1038/s41392-020-0110-5 (Q9815)‏‎ (2 links)
  2. Xu J, et al, medRxiv (2020), cited as Ref 1 in DOI:10.14218/ERHM.2020.00023 (Q10776)‏‎ (2 links)
  3. Aicardi-Goutieres syndrome (disease - MeSH supplementary concept)‏‎ (2 links)
  4. Zhou J, et al. Proc. Natl Acad. Sci. USA (2007) cited as Ref 328 in DOI: 10.1038/s41392-020-0110-5 (Q9591)‏‎ (2 links)
  5. Lauth M, et al. Proc. Natl Acad. Sci. USA (2007) cited as Ref 617 in DOI: 10.1038/s41392-020-0110-5 (Q9880)‏‎ (2 links)
  6. Husnayain A, et al, Int J Infect Dis (2020), cited as Ref 9 in DOI:10.14218/ERHM.2020.00023 (Q10784)‏‎ (2 links)
  7. Jia H, et al. Oncogene (2017) cited as Ref 336 in DOI: 10.1038/s41392-020-0110-5 (Q9599)‏‎ (2 links)
  8. Braden Mann kickoff for 65 yds for a touchback (10-7-17c)‏‎ (2 links)
  9. Transitional segment 51 (Q14839)‏‎ (2 links)
  10. Jimeno A, et al. Clin. Cancer Res. (2013) cited as Ref 625 in DOI: 10.1038/s41392-020-0110-5 (Q9888)‏‎ (2 links)
  11. McIntosh K, et al, Uptodate (2020), cited as Ref 17 in DOI:10.14218/ERHM.2020.00023 (Q10792)‏‎ (2 links)
  12. Romero D, et al. Carcinogenesis (2016) cited as Ref 344 in DOI: 10.1038/s41392-020-0110-5 (Q9607)‏‎ (2 links)
  13. Ruan Q, et al, Intensive Care Med (2020), cited as Ref 7 in DOI: 10.1007/s11886-020-01293-2 (Q11001)‏‎ (2 links)
  14. Hainsworth JD, et al. Target Oncol. (2016) cited as Ref 633 in DOI: 10.1038/s41392-020-0110-5 (Q9896)‏‎ (2 links)
  15. Ellwood-Yen K, et al. Cancer Cell (2003) cited as Ref 120 in DOI: 10.1038/s41392-020-0110-5 (Q9383)‏‎ (2 links)
  16. Tasian SK, et al. Front. Oncol. (2014) cited as Ref 352 in DOI: 10.1038/s41392-020-0110-5 (Q9615)‏‎ (2 links)
  17. Sungnak W, et al, arXiv (2020), cited as Ref 15 in DOI: 10.1007/s11886-020-01293-2 (Q11009)‏‎ (2 links)
  18. JK Scott kickoff for 63 yds Clyde Chriss return for 12 yds to the TexAM 29 (10-7-17) (Q2749)‏‎ (2 links)
  19. Sullivan RJ, et al. Nat. Med. (2019) cited as Ref 641 in DOI: 10.1038/s41392-020-0110-5 (Q9904)‏‎ (2 links)
  20. Kikuchi A, et al. Int. Rev. Cell. Mol. Biol. (2011) cited as Ref 128 in DOI: 10.1038/s41392-020-0110-5 (Q9391)‏‎ (2 links)
  21. Yuzugullu H, et al. Nat. Commun. (2015) cited as Ref 360 in DOI: 10.1038/s41392-020-0110-5 (Q9623)‏‎ (2 links)
  22. HFSA/ACC/AHA, et al, (Accessed April 1, 2020), cited as Ref 23 in DOI: 10.1007/s11886-020-01293-2 (Q11017)‏‎ (2 links)
  23. Bao B, et al. Current protocols in pharmacology Chapter 14:Unit14.25 (2013) cited as Ref 649 in DOI: 10.1038/s41392-020-0110-5 (Q9912)‏‎ (2 links)
  24. Mazzoni SM, et al. Cancer Lett. (2014) cited as Ref 136 in DOI: 10.1038/s41392-020-0110-5 (Q9399)‏‎ (2 links)
  25. Muscle Weakness (disease - MeSH descriptor) (Q10840)‏‎ (2 links)
  26. CD4 molecule (gene)‏‎ (2 links)
  27. JK Scott kickoff for 64 yds Kalija Lipscomb return for 13 yds to the Vandy 14 (9/23/17)‏‎ (2 links)
  28. Chang L, et al. Cell death Dis. (2013) cited as Ref 368 in DOI: 10.1038/s41392-020-0110-5 (Q9631)‏‎ (2 links)
  29. Harris JE, et al, Int J Cardiol Heart Vasc (2019), cited as Ref 31 in DOI: 10.1007/s11886-020-01293-2 (Q11025)‏‎ (2 links)
  30. Moselhy J, et al. Anticancer Res. (2015) cited as Ref 657 in DOI: 10.1038/s41392-020-0110-5 (Q9920)‏‎ (2 links)
  31. Clever, H, et al. Cell (2012) cited as Ref 144 in DOI: 10.1038/s41392-020-0110-5 (Q9407)‏‎ (2 links)
  32. ALA Kickoff (11/7/1992b) (Q7224)‏‎ (2 links)
  33. Jensen RH, et al, PLoS ONE (2015), cited as Ref 105 in DOI: 10.3390/v12020211 (Q10184)‏‎ (2 links)
  34. Al-Hajj M, et al. Proc. Natl Acad. Sci. USA (2003) cited as Ref 29 in DOI: 10.1038/s41392-020-0110-5 (Q9292)‏‎ (2 links)
  35. Vasilyev EV, et al, Virol. J. (2009), cited as Ref 113 in DOI: 10.3390/v12020211 (Q10192)‏‎ (2 links)
  36. Cojoc M, et al. Semin. Cancer Biol. (2015) cited as Ref 37 in DOI: 10.1038/s41392-020-0110-5 (Q9300)‏‎ (2 links)
  37. Jalen Hurts run for no gain to the TexAM 49 (10-7-17)‏‎ (2 links)
  38. Eddie Versprille (Q7727)‏‎ (2 links)
  39. Palser AL, et al, J. Virol. (2015), cited as Ref 121 in DOI: 10.3390/v12020211 (Q10200)‏‎ (2 links)
  40. of liver in amoebic dysentery, 513 (Index entry from HathiTrust item t54f2j58c) (Q11486)‏‎ (2 links)
  41. de Wynter EA, et al. Stem Cells (1995) cited as Ref 45 in DOI: 10.1038/s41392-020-0110-5 (Q9308)‏‎ (2 links)
  42. Jimmy Camacho kickoff for 65 yds for a touchback (9/9/17b) (Q5044)‏‎ (2 links)
  43. Singh RK, et al, Front. Microbiol. (2018), cited as Ref 129 in DOI: 10.3390/v12020211 (Q10208)‏‎ (2 links)
  44. JK Scott kickoff for 62 yds Reginald Todd return for 22 yds to the MisSt 40 (11/11/17) (Q3643)‏‎ (2 links)
  45. Feuring-Buske M, et al. Blood (2001) cited as Ref 53 in DOI: 10.1038/s41392-020-0110-5 (Q9316)‏‎ (2 links)
  46. No cited references in this section (Q8386)‏‎ (2 links)
  47. ALA Kickoff (11/7/1992d)‏‎ (2 links)
  48. Chrzastek K, et al, Virology (2017), cited as Ref 137 in DOI: 10.3390/v12020211 (Q10216)‏‎ (2 links)
  49. ====>symptoms of, 628 (Index entry from HathiTrust item t54f2j58c) (Q11502)‏‎ (2 links)
  50. Taylor MD, et al. Cancer Cell (2005) cited as Ref 61 in DOI: 10.1038/s41392-020-0110-5 (Q9324)‏‎ (2 links)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://wikibase.slis.ua.edu/wiki/Special:MostLinkedPages"